Advertising Age Article Abstract
Carat Keeps $1.2 Billion Pfizer Media After Review
Longtime Relationship Unaffected by Pharma Company's Consolidation Deal
NEW YORK (AdAge.com) -- Pfizer is keeping its estimated $1.2 billion media planning and buying business at Aegis' Carat after a review that launched in September. The move comes after the pharma company earlier this year consolidated all media buying for its Wyeth DTC brands under Carat. ...